STOCKSCREENR
Log In

PCLO.V

TSXV

PharmaCielo Ltd.

$0.07+0.01(+7.69%)Mkt Cap: $13.16M

Key Stats

Market Cap

$13.16M

P/E Ratio

-1.40

EPS

$-0.05

Dividend Yield

0.00%

52-Week Range

$0.03 — $0.17

Volume

15.70K

Avg Volume

85.18K

Beta

0.16

Valuation

P/E (TTM)

-1.40

Forward P/E

—

PEG Ratio

-0.08

P/S (TTM)

3.96

P/B (TTM)

-0.67

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

0.36%

ROA (TTM)

-0.53%

ROIC

—

Gross Margin

0.29%

Operating Margin

-1.46%

Net Margin

—

Debt/Equity

-1.21

Current Ratio

0.15

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+0.46%

EPS Growth (5Y)

+0.37%

Sales Growth (3Y)

+0.76%

Sales Growth (5Y)

+0.88%

EPS Est (This Year)

—

EPS Est (Next Year)

—

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.00

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

187.98M

Float

172.32M

Free Float %

91.67%

About

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

CA

Exchange

TSXV

IPO Date

2019-03-04

Employees

268

CEO

Marc Lustig

Index Membership

—

Website

https://www.pharmacielo.com

PharmaCielo Ltd. (PCLO.V) is a healthcare company in the drug manufacturers - specialty & generic industry listed on the TSXV. With a market capitalization of $13.16M, a P/E ratio of -1.40, PCLO.V is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare PCLO.V against other stocks using dozens of fundamental and technical filters.

Similar Stocks

DHB.V

Delivra Health Brands Inc.

$0.19

+0.00%

$5.94M

ROMJ.V

Rubicon Organics Inc.

$0.51

+4.08%

$34.26M

HASH.V

Simply Solventless Concentrates

$0.06

+37.50%

$6.35M

SNOA

Sonoma Pharmaceuticals, Inc.

$2.40

+0.00%

$4.15M

CPIX

Cumberland Pharmaceuticals Inc.

$3.01

-1.63%

$45.02M

SCYX

SCYNEXIS, Inc.

$0.92

+2.39%

$41.11M

Frequently Asked Questions

What is PharmaCielo Ltd.'s P/E ratio?

PharmaCielo Ltd. (PCLO.V) has a trailing twelve-month (TTM) P/E ratio of -1.40. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does PharmaCielo Ltd. pay a dividend?

No, PharmaCielo Ltd. (PCLO.V) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is PharmaCielo Ltd.'s market cap?

PharmaCielo Ltd. (PCLO.V) has a market capitalization of $13.16 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.